If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
790.00    9.00 (1.15%)
Bid:
787.00
Ask:
790.50
Spread: 3.50 (0.445%)
Market Cap: £893.58m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Board Change

30 Jun 2026 09:42

RNS Number : 3765K
Fevertree Drinks PLC
30 June 2026
 

30 June 2026

 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Board Change

 

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that Laura Hagan has informed the Board of her decision to step down as a Non-Executive Director of the Company with effect from the end of July 2026.

 

Laura joined the Board in May 2021 and has served as Chair of the Remuneration Committee and as a member of the Audit and Nomination Committees. During her tenure, she has made a significant contribution to the Board, bringing extensive HR, governance, listed company and relevant industry experience, together with valuable insight and constructive challenge as the business has continued to evolve.

 

Commenting on Laura's departure, Domenic De Lorenzo, Chair of Fever-Tree, said: "On behalf of the Board, I would like to thank Laura for her commitment and valued contribution over the past five years. She has been an excellent colleague, providing thoughtful counsel and sound judgement throughout her time with Fever-Tree. We are grateful for her support and wish her every success for the future and the rest of her portfolio career."

 

Laura Hagan said: "It has been a privilege to serve on the Fever-Tree Board and to work alongside Dom, Tim, Andy and my fellow Directors during an exciting period for the business. Fever-Tree is a fantastic company with a strong brand, talented people and significant opportunities ahead. I wish the Board and everyone at Fever-Tree continued success for the future."

 

Following Laura's departure, David Lapp will assume the role of Chair of the Remuneration Committee. David joined the Board in January 2024 and brings extensive international commercial and leadership experience.

 

 

 Ends

 

For further information:

 

Investor queries

Steve Nightingale, Investor Relations Director I steve.nightingale@fever-tree.com I

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I +44 (0)20 7597 5970

Corporate Broker - Jefferies International Limited

Ed Matthews I Richard Taylor I +44 (0)20 7029 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0) 7826 534 233

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASDSSASEMSELM
Date   Source Headline
27th Jul 20157:00 amRNSInterim Results
9th Jul 20154:45 pmRNSHolding(s) in Company
9th Jul 20153:50 pmRNSHolding(s) in Company
9th Jul 20152:30 pmRNSHolding(s) in Company
8th Jul 20154:59 pmRNSSale of Ordinary Shares in Fever-Tree
8th Jul 20154:49 pmRNSDirector/PDMR Shareholding
8th Jul 20157:00 amRNSPre-Close Trading Statement
19th Jun 20155:35 pmRNSFever-Tree TR-1
29th May 20153:20 pmRNSHolding(s) in Company
7th May 20155:26 pmRNSResult of AGM
9th Apr 20157:00 amRNSHolding(s) in Company
7th Apr 20153:30 pmRNSHolding(s) in Company
7th Apr 20157:00 amRNSHolding(s) in Company
2nd Apr 20155:02 pmRNSSale of Ordinary Shares in Fever-Tree
1st Apr 20157:00 amRNS2014 Annual Report and Notice of AGM
23rd Mar 20157:00 amRNSPreliminary Results 2014
22nd Jan 20157:00 amRNSPre-Close Trading Statement
15th Jan 20154:17 pmRNSHolding(s) in Company
8th Jan 20153:05 pmRNSHolding(s) in Company
7th Jan 20159:26 amRNSHolding(s) in Company
23rd Dec 20147:00 amRNSNotice of pre-close Trading Statement
17th Nov 20144:18 pmRNSHolding(s) in Company
17th Nov 20144:16 pmRNSHolding(s) in Company
7th Nov 20147:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.